FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Group",
  "id": "236949",
  "meta": {
    "versionId": "72",
    "lastUpdated": "2026-01-29T20:46:33.135Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
      "valueRelatedArtifact": {
        "type": "part-of",
        "resourceReference": {
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "MAGIC-5288-j1Wqrn-conversion-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
        }
      }
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown": "SGLT2 inhibitors Group in Adults with type 2 diabetes [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236949. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236949. Computable resource at: https://fevir.net/resources/Group/236949#json."
    }
  ],
  "url": "https://fevir.net/resources/Group/236949",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "236949",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "title": "SGLT2 inhibitors Group in Adults with type 2 diabetes",
  "status": "active",
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors",
  "useContext": [
    {
      "code": {
        "system": "https://fevir.net/resources/CodeSystem/179423",
        "code": "evidence-communication",
        "display": "Evidence Communication"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "ExposureGroup",
            "display": "ExposureGroup"
          }
        ]
      }
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "type": "person",
  "membership": "enumerated",
  "combinationMethod": "all-of",
  "characteristic": [
    {
      "code": {
        "text": "Member of"
      },
      "valueReference": {
        "reference": "Group/236947",
        "type": "Group",
        "identifier": {
          "type": {
            "text": "FEvIR Linking Identifier"
          },
          "system": "https://fevir.net/FLI",
          "value": "MAGIC-5288-j1Wqrn-population-group-85394-85798",
          "assigner": {
            "display": "Computable Publishing LLC"
          }
        },
        "display": "Adults with type 2 diabetes and CVD and CKD"
      },
      "exclude": false,
      "description": "inclusion in Adults with type 2 diabetes"
    },
    {
      "code": {
        "text": "Exposed to"
      },
      "valueReference": {
        "reference": "Group/236769",
        "type": "Group",
        "identifier": {
          "type": {
            "text": "FEvIR Linking Identifier"
          },
          "system": "https://fevir.net/FLI",
          "value": "MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
          "assigner": {
            "display": "Computable Publishing LLC"
          }
        },
        "display": "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors"
      },
      "exclude": false,
      "description": "received SGLT2 inhibitors"
    }
  ]
}